The Biostatistics Core provides comprehensive data processing and analysis services for the Specialized Research Center (P50), on """"""""Evaluating New Nicotine Standards for Cigarettes"""""""". These include form design, study design, and statistical analysis. These services will be provided to investigators and leaders of the four main projects in the proposed specialized research center, as well as to Cores A and B if necessary. The Core director. Dr. Chap Le, and Core co-director. Dr. Xianghua Luo, who will manage and direct the Core, have extensive experience in the areas of biostatistics and tobacco research and also manage many similar large projects in the Biostatistics and Bioinformatics Core of the University of Minnesota Comprehensive Cancer Center. Statistical expertise in the Core is particularly noteworthy in regard to the projects proposed for this P50 which include several randomized trials. It is believed that this group will be an important and essential asset to investigators of this specialized research center.

Public Health Relevance

The goal of the Biostatistics Core, Core C, is to support and promote high quality, team-oriented, and transdisciplinary research on tobacco evaluation as proposed in this grant application. The Core will be responsible for assisting the Project Leaders in study design, data collection and processing, quality control, data storage and retrieval, and statistical data analysis.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54DA031659-04
Application #
8710135
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
Kazi, Abid; Fazzi, Alyse; Krebs, Nicolle M et al. (2018) Cigarette Management System: An operating procedures guide to obtaining and managing investigational tobacco products for regulatory science research. Contemp Clin Trials Commun 11:69-74
Hatsukami, Dorothy K; Luo, Xianghua; Jensen, Joni A et al. (2018) Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial. JAMA 320:880-891
Boatman, Jeffrey A; Vock, David M; Koopmeiners, Joseph S et al. (2018) Estimating causal effects from a randomized clinical trial when noncompliance is measured with error. Biostatistics 19:103-118
Hatsukami, Dorothy K; Donny, Eric C (2018) The Debate About Nicotine Addiction and the Role of Medicinal Products: Commentary on Zeller. Nicotine Tob Res :
Smith, Tracy T; Hatsukami, Dorothy K; Benowitz, Neal L et al. (2018) Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health. Prev Med 117:8-14
Dermody, Sarah S; McClernon, F Joseph; Benowitz, Neal et al. (2018) Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence. Exp Clin Psychopharmacol 26:223-232
Tidey, Jennifer W; Davis, Danielle R; Miller, Mollie E et al. (2018) Modeling nicotine regulation: A review of studies in smokers with mental health conditions. Prev Med 117:30-37
Ho, Yen-Yi; Nhu Vo, Tien; Chu, Haitao et al. (2018) A Bayesian hierarchical model for demand curve analysis. Stat Methods Med Res 27:2038-2049
Streck, Joanna M; Bergeria, Cecilia L; Parker, Maria A et al. (2018) Response to reduced nicotine content cigarettes among smokers with chronic health conditions. Prev Med Rep 12:321-329
Pacek, Lauren R; Joseph McClernon, F; Denlinger-Apte, Rachel L et al. (2018) Perceived nicotine content of reduced nicotine content cigarettes is a correlate of perceived health risks. Tob Control 27:420-426

Showing the most recent 10 out of 63 publications